SCHEMBL9921328

SCHEMBL9921328

Cc1nc(NCCc2ccc(C(F)(F)F)cc2)c2cc(F)ccc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 1/20 0.50
▸ SOS1 Q07889 1/20 0.50
▸ HTT P42858 1/20 0.49
▸ PDE2A O00408 1/20 0.47
▸ GRK6 P43250 1/20 0.45
▸ CTNNB1 P35222 4/20 0.44
▸ TCF7L2 Q9NQB0 4/20 0.44
▸ CCNC P24863 1/20 0.43
▸ CDK8 P49336 1/20 0.43
▸ ACP1 P24666 1/20 0.43
▸ MCHR1 Q99705 2/20 0.42
▸ GABBR2 O75899 1/20 0.41
▸ GABBR1 Q9UBS5 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ NTRK1 P04629 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ APP P05067 1/20 0.40
▸ BCHE P06276 1/20 0.40
▸ ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13192084 0.87 HTT (0.50) HTTPDE2AGRK6CTNNB1TCF7L2
SCHEMBL9921339 0.85 HTT (0.51) HTTPDE2AGRK6CTNNB1TCF7L2
SCHEMBL9921340 0.84 HTT (0.50) KRASSOS1HTTPDE2AGRK6
SCHEMBL9921332 0.82 PDE2A (0.47) HTTPDE2ACCNCCDK8ACP1
SCHEMBL13171126 0.81 HTT (0.49) HTTGRK6CTNNB1TCF7L2ALDH1A1
SCHEMBL9921377 0.81 HTT (0.74) HTTCCNCCDK8NTRK1LMNA
SCHEMBL13171146 0.75 HTT (0.53) HTTGRK6CTNNB1TCF7L2ALDH1A1
SCHEMBL9921433 0.74 HTT (0.64) HTTCCNCCDK8MCHR1LMNA
SCHEMBL13171145 0.74 HTT (0.52) HTTGRK6CTNNB1TCF7L2ALDH1A1
SCHEMBL4864860 0.72 LMNA (0.65) HTTALDH1A1LMNAMAPTAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 — — US disclosed
WO-2012079079-A1 PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-06-14 — — WO disclosed
WO-2011011522-A2 POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-01-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof ATG7, BECN1, SQSTM1 KRAS 169/4885SOS1 2247/4885HTT 4078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback